Epitalon
Epitalon (Epithalon / Epithalamin Synthetic Analog)
Also known as: Epithalon, Epithalone, AEDG peptide, Epithalamin
Prompted by Jack Butcher (Visualize Value) · AI-authored by Claude · Research-sourced
A synthetic tetrapeptide researched for telomerase activation by Khavinson's group over 30 years. Animal studies show lifespan extension, but evidence comes primarily from one research group and lacks Western replication.
Quick Facts
Not FDA-approved for human use. Epitalon is a research compound primarily studied in Russia. It has not been evaluated by the FDA or EMA for any clinical indication.
Overview
Epitalon (also spelled Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) that represents the active sequence of epithalamin, a polypeptide extract of the bovine pineal gland. It was developed and extensively researched by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia over a research program spanning more than 30 years.
The primary research interest in epitalon centers on its reported ability to activate the enzyme telomerase, which adds telomeric repeats (TTAGGG) to the ends of chromosomes. Telomere shortening is a fundamental mechanism of cellular aging — each cell division erodes telomere length until a critical threshold triggers cellular senescence or apoptosis. By reactivating telomerase in somatic cells, epitalon theoretically extends the replicative lifespan of cells.
Additionally, epitalon has been studied for its effects on melatonin production, neuroendocrine regulation, and antioxidant defense systems. Khavinson's research group has published studies reporting lifespan extension in animal models and improvements in biomarkers of aging in elderly human subjects treated with epithalamin and epitalon.
Mechanism of Action
Epitalon's primary proposed mechanism is the activation of telomerase — a ribonucleoprotein enzyme that synthesizes telomeric DNA repeats at chromosome ends. Telomerase consists of a catalytic protein subunit (hTERT) and an RNA template component (hTR/TERC). Epitalon is reported to upregulate hTERT gene expression, reactivating telomerase in somatic cells where it is normally silenced.
In cell culture studies, Khavinson and colleagues demonstrated that epitalon induced telomerase activity in human fetal fibroblasts and pulmonary fibroblasts from elderly donors. The treated cells showed elongation of telomeres and extended replicative capacity, surpassing the Hayflick limit by 10 additional population doublings.
Beyond telomerase activation, epitalon appears to modulate pineal gland function. It has been shown to stimulate melatonin production in elderly individuals whose melatonin synthesis has declined with age. This neuroendocrine effect may contribute to improved circadian rhythm regulation, sleep quality, and antioxidant defense, as melatonin is a potent endogenous antioxidant.
Epitalon has also been reported to influence the expression of genes involved in antioxidant defense (superoxide dismutase, glutathione peroxidase), DNA repair, and apoptosis regulation. These effects suggest a broad bioregulatory role rather than action through a single classical receptor pathway.
It is important to note that while the proposed mechanisms are biologically plausible, the research has been conducted primarily by a single research group, and independent replication in Western laboratories has been limited.
Research Summary
The bulk of epitalon research originates from Professor Khavinson's group at the Saint Petersburg Institute of Bioregulation and Gerontology. Their work spans cell culture studies, animal models, and human clinical observations over three decades.
In cell culture, Hayflick and Khavinson demonstrated that epitalon reactivated telomerase and extended replicative capacity in human somatic cells. Treated cells exceeded the Hayflick limit and showed elongated telomeres compared to untreated controls.
Animal studies in mice and rats reported extended mean and maximum lifespan. In a study of female CBA mice, chronic epitalon administration extended mean lifespan by approximately 12% and maximum lifespan by approximately 13%. Similar results were observed in Drosophila melanogaster, where epitalon extended mean lifespan by 11–16%.
Human studies include observational and clinical investigations of epithalamin (the natural pineal extract, of which epitalon is the synthetic analog). A 6-year observational study in elderly patients reported reduced cardiovascular mortality and improved functional status in subjects receiving epithalamin courses compared to controls. A 15-year follow-up study by Khavinson et al. reported reduced mortality in elderly participants treated with thymic and pineal peptide bioregulators.
Critical limitations: Most studies come from a single research group. Many of the animal and human studies were conducted in Russia and published in Russian-language journals or journals with limited international peer review. Independent Western replication is largely absent. The human studies are observational or small-scale, not large randomized controlled trials by modern standards.
Key References
Peptide promotes overcoming of the division limit in human somatic cells
Khavinson VKh, et al. · Bulletin of Experimental Biology and Medicine (2004) · 10.1023/B:BEBM.0000046008.27301.a1
Demonstrated that epitalon reactivated telomerase and enabled human fibroblasts to exceed the Hayflick limit by 10 additional population doublings, with concurrent telomere elongation.
Effect of epithalon on the lifespan increase in Drosophila melanogaster
Anisimov VN, et al. · Mechanisms of Ageing and Development (2001) · 10.1016/S0047-6374(01)00299-7
Demonstrated 11–16% extension of mean lifespan in Drosophila with chronic epitalon administration, providing cross-species evidence for anti-aging effects.
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
Khavinson VKh, et al. · Bulletin of Experimental Biology and Medicine (2003) · 10.1023/A:1026372916714
Cell culture study showing epitalon-induced telomerase activation and telomere length increase in pulmonary fibroblasts from elderly donors, establishing the telomerase mechanism.
Effect of peptide bioregulators on mortality in elderly patients: 15-year follow-up
Khavinson VKh, Morozov VG. · Bulletin of Experimental Biology and Medicine (2003) · 10.1023/A:1024641215716
Fifteen-year follow-up study reporting 28% reduction in mortality among elderly subjects treated with thymic and pineal peptide bioregulators compared to controls.
Protocols
Standard cycle (research-based)
The most commonly cited protocol from Khavinson's research. Administered as short intensive courses rather than continuous use. Some protocols specify 10 mg daily for 10 days, repeated every 6 months. Typically injected in the evening to align with pineal gland circadian activity.
Extended low-dose protocol
Lower dose, longer course variant. Some practitioners prefer this approach for a more gradual effect. Inject in the evening or before bedtime. Rest period between courses allows assessment of response.
Side Effects & Safety
| Frequency | Effect |
|---|---|
| common | Injection site irritation Mild redness or discomfort at the injection site. Generally transient and self-resolving. |
| uncommon | Drowsiness May be related to increased melatonin production, particularly with evening dosing. Can be considered a therapeutic effect. |
| uncommon | Headache Reported anecdotally. Usually mild and self-limiting. |
| uncommon | Vivid dreams Reported by some users, potentially related to enhanced melatonin production and altered sleep architecture. |
Contraindications
- —Active cancer or history of cancer (telomerase activation could theoretically promote cancer cell immortalization)
- —Pregnancy or breastfeeding (insufficient safety data)
- —Autoimmune conditions (insufficient data on immune modulation effects)
- —Known hypersensitivity to epitalon or any excipients
Interactions
- —May potentiate the effects of exogenous melatonin supplements (additive melatonin elevation)
- —Theoretical interaction with immunosuppressive medications (epitalon may have immunomodulatory properties)
- —No well-characterized drug-drug interactions have been established in clinical studies
Reconstitution & Storage
Related Peptides
Epitalon is often discussed alongside other longevity-focused peptides. GHK-Cu promotes tissue remodeling and gene expression resetting, while epitalon targets telomere biology. Some longevity protocols combine pineal bioregulators with thymic peptides (thymalin/thymulin) based on Khavinson's bioregulation framework.